Preventing COPD with Beta Blockers

Trial Objective

The purpose of this study is to see if Metoprolol, a commonly prescribed heart medication, can reduce the frequency and severity of COPD flare-ups.

Preventing COPD Flare-Ups with Beta Blockers

Enrollment

This trial is active and currently recruiting.

How to Participate

For more information, contact the study coordinator at 303.398.1518 or complete the form below.

Who Can Participate

Participation involves 10 visits to the research clinic and 10 phone visits over one year. Medication and testing (heart and lung) provided at no cost.

Qualifications include:

  • Male or female age 40-85
  • Antibiotic or steroid use for COPD flare-up within past year OR
  • On oxygen for more than 12 hours per day


Age

40-85


Gender

Any Gender

Trial Location

National Jewish Main Campus, Denver, CO

Compensation

Provided

Trial Sponsors

Department of Defense, Office of the Congressionally Directed Medical Research Programs


Estimated Time Commitment

10 visits & 10 phone visits over 1 year

Principal Investigators

Co-Investigators


Request More Information

*
*
*
*